Prednisolone plus a disease-modifying antirheumatic drug improved outcomes in early rheumatoid arthritis
- PMID: 16646617
Prednisolone plus a disease-modifying antirheumatic drug improved outcomes in early rheumatoid arthritis
Comment on
-
Low-dose prednisolone in addition to the initial disease-modifying antirheumatic drug in patients with early active rheumatoid arthritis reduces joint destruction and increases the remission rate: a two-year randomized trial.Arthritis Rheum. 2005 Nov;52(11):3360-70. doi: 10.1002/art.21298. Arthritis Rheum. 2005. PMID: 16255010 Clinical Trial.